What is Roth Capital’s Forecast for APVO FY2029 Earnings?
Aptevo Therapeutics Inc. (NASDAQ:APVO – Free Report) – Analysts at Roth Capital issued their FY2029 earnings estimates for Aptevo Therapeutics in a research report issued on Monday, February 17th. Roth Capital analyst J. Aschoff expects that the biotechnology company will post earnings per share of $2.84 for the year. The consensus estimate for Aptevo Therapeutics’ […]
Aptevo Therapeutics Inc. (NASDAQ:APVO – Free Report) – Analysts at Roth Capital issued their FY2029 earnings estimates for Aptevo Therapeutics in a research report issued on Monday, February 17th. Roth Capital analyst J. Aschoff expects that the biotechnology company will post earnings per share of $2.84 for the year. The consensus estimate for Aptevo Therapeutics’ […]
